CUISINE DOCTORS

Healthcare Times YouTube Channel

The only dedicated Healthcare YouTube Channel promoting the best Hospital brands in India

In Association with

Identity Space – Healthcare Media Agency &

Healthcare Radius, leading B2B healthcare magazine

About:Healthcare Times is an upcoming YouTube channel featuring leading Indian hospital brands and clinics offering wide choices of treatments for individuals seeking medical help. Healthcare Times You Tube channel promotes India as a top medical destination for domestic and international patient in particular. The channel broadcasts eminent leaders in healthcare, their future vision and growth plans, How modern technology is transforming medical treatment in India, Latest trends in healthcare and wellness, Presenting breakthrough medical cases successfully executed by skilled Indian doctors and much more

The India’s medical tourism market is expected to more than double in size from USD 3 billion at present to around USD 8 billion by 2020, a report says.

For 80% Medical Tourist cost is a major driver and our closest neighbors are not behind in offering this competitiveness. Though India is capitalizing on it strengths but we are also challenged by our neighbors We have best accredited facilities and top class doctors tackling the most complicated cases with utmost success rate. Today Africa, GCC and CIS regions (whose current share is just 30 per cent) present the maximum possible opportunity for the Indian healthcare sector. Medical tourists from these sectors currently favour the South East Asian medical corridors.

Reflecting the pulse of the vibrant industry, Healthcare Radius is bringing out the second edition of the medical tourism handbook- an over 100-page reference guide to the world of medical tourism. Releasing in April 2017, the 2nd edition promises to cover topics that will showcase Indian Hospitals as front runners in international medical tourism sector. Please read below

Contents of Handbook:

International healthcare buyers: How to find them

International – Building strategic relationship will emerging patient destinations

4000 copies will be printed and circulated to targeted readers in India, these include Medical Tour operators, Facilitating companies, Insurance companies, Assistance companies, Foreign Embassies in India, Authoritative healthcare bodies and agencies in India, Tourism and Health Ministry etc. This year we are enhancing international readership, MTIH will be digitised and reach international operators, International Physicians in Africa, GCC , CIS and SAARC regions. Specials mailers will be designed to promote the handbook at international level

Advertising Opportunities: Categories include

Presenting Sponsor

Specialty Hospital Partner

Section Sponsorship

Regular Advertisements

Booklet inserts

Innovations – Planner

We invite your participation and ardent supporting in making this industry initiative a grand success. We will be glad to address your queries if any.

India is fast emerging as the top medical tourism destination and is globally recognised for quality medical care, excellent services and competitive pricing. Our holistic medicine synergies are MT’s biggest attractions in India. Our Indian healthcare brand is synonymous with “safety trust and excellence”. Thus it is clear that the opportunities and challenges for growth in the health sector are lurking and our industry needs to collective address issue that plagues MT growth.

I am pleased to bring to your kind attention that in March 2017 our industry will be witnessing 2 prominent medical tourism exhibition collectively bringing together the best hospital brands and eminent personalities on single networking and discussion platform. Healthcare Radius announces it collaboration with World Medical Tourism Congress 2017 & International Healthcare Tourism Congress 2017 as media partners

1] World Medical Tourism Congress India 2017 is being held on 7th -8th March 2017 in New Delhi.The World Medical Tourism Congress India sees the entry of the largest medical tourism event organizer in the world – WMTC into the Indian market in partnership with The Times Group India’s leading media group. The objective is to further leverage on India’s capabilities in the medical sector backed by a strong value proposition. This would help pole vault India ranked currently 5th in the Global Medical Tourism market and establish it as a hub for medical tourism. Event will provide an international dimension to the MT trade with renowned international speakers propagating modern trends and presenting global opportunities in the sector. An international hosted buyer program presents business prospects from across borders.

2] International Healthcare Tourism Congress 2017 being held in Bangalore from 3rd -4th March 2017IHTC is the most comprehensive international healthcare conference and tradeshow in the industry. The event will offer an opportunity to interact with leaders in medical tourism industry, both from local and global partnerships. This will be a platform for Pharma company’s, hospitals, Medical Tourism Agents, Insurance Companies, Medical Technology Manufactures, Wellness and hospitality Industry and healthcare investors to meet & associate. There is a special hosted buyer program announced for Medical Tourism Agencies (MTA) which will provide a pre-set number of discounts for registrations, complimentary registrations, local hospitality and travel allowance to selected companies, government employees, insurance agents and other qualified buyers as beneﬁts for Medical tourism facilitators.

Healthcare Radius plan to publish a exclusive medical tourism special feature in its March ’17 edition with special coverage to these 2 events and provide updates on new trends prevailing in international circuits. This features also provides an opportunity for Indian hospital to display their positioning in a global environment via our publication.
Health Radius magazine ensures to be circulated at these event along with a special digital promotion of the magazine to international audience that matters. We invite your participation in this high impact feature.

Continuing its strong streak in Meaningful Use (MU), MEDHOST, a leading provider of enterprise solutions for healthcare management systems, today announced that its Business Intelligence solution has achieved MU Stage 3 certification for Clinical Quality Measures (CQM) 2015.1

MEDHOST partnered with CitiusTech, a leading provider of healthcare technology services and solutions, to leverage its healthcare BI and analytics capabilities. CitiusTech enabled MEDHOST to enhance its MU Stage 3 certified solution with its advanced CQM capabilities for MU reporting. MEDHOST Business Intelligence is a SaaS-based and a cloud-based executive dashboard, for C-level executives and quality administrators, which helps monitor actionable data for MU reporting. With hundreds of clinical and financial key performance indicators (KPIs) to analyze, Business Intelligence provides deep insight into operational and financial measures, increasing visibility enterprise-wide so that organizations can improve overall facility performance.

“Attaining Meaningful Use Stage 3 certification is just a part of our larger mission to better equip our clients to provide coordinated care with maximum business efficiency,” said Bill Anderson, Chairman and Chief Executive Officer, MEDHOST. “MEDHOST Business Intelligence solution has extensive capabilities that help our clients meet pay-for-performance requirements, submit outcomes data, perform benchmarking and analytics to optimize clinical and revenue cycle processes, and engage with their clients through intuitive consumer portals.”

“Delivering fewer medical errors and managing alerting across systems is a key to ensuring effective patient care. Our partnership with MEDHOST has enabled us to build a robust solution which helps ensure clinical accuracy and patient safety, allowing greater ease of electronic flow of information between patients and providers,” said Rizwan Koita, Chief Executive Officer, CitiusTech.

BI-Clinical, CitiusTech’s healthcare BI/ analytics platform, is a certified platform for both provider organizations (e.g. Meaningful Use, PQRS, MIPS/ MACRA) and payer organizations (e.g. NCQA and HEDIS). BI-Clinical consists of a library of more than 600 pre-built KPIs, is deployed over 4,500 locations, supports over 550,000 providers and impacts over 30 million lives.

·More than 64 percent of patients in the West were diagnosed with cancer in the second or later stage

·70 percent people had to go through multiple level of testing leading to delay in the onset of treatment

·57 percent patients had to wait for more than 3 months for a confirmed diagnosis

Gleneagles Global Hospitals today released its ‘Painful Wait’ report that aims at highlighting the difficulties faced by cancer patients during their journey from diagnosis to treatment and thereby identify the key ‘Painful Wait’ areas. This is a national level study commissioned by Gleneagles Global Hospitals in collaboration with CubeX Sorento Health.

The main Painful Wait areas that have been identified include initial symptom recognition and diagnosis, access to cancer diagnostic tests, multiple diagnostic tests, time taken from diagnosis to confirmation, poor access to oncologists, initiation of treatment, satisfaction with hospitals and cost of treatment.

In the area of initial symptom recognition, there is a stark contradiction in the perceived ability of family physicians to understand the symptoms. Respondents in the south (97%) said their family physicians were effective in understanding the symptoms. However, respondents in East (71%), West (69%) and North (47%) opined that their family physicians could not gauge the signs of cancer to correctly route them to specialist. Delay in effectively gauging the signs of cancer at the primary care level delays timely diagnosis and treatment. Hence, the ability of the family physician to gauge early signs of cancer and patient awareness is crucial reported the study.

With regard to screening and diagnosis, less than half the respondents (46%) reported that cancer was detected at stage 1; lowest being in the west (39%) and North (20%) were diagnosed at stage IV. While, 70% respondents got confirmation of diagnosis within 3 months, in west and south the value is low. This indicates the need for faster access to specialized tests and the availability of timely tests results and accurate interpretation to initiate treatment.

Multiple diagnostic tests were another area of concern. About 7 out of every 10 respondents had to perform several tests on visiting different oncologists. Every respondent in the south (100%) and 70% from the north had to re-do the tests. Poor access to oncologists is a key concern of diagnosis (49%). Faster access to cancer specialists will avoid repeated/multiple tests and agony of patients, commented the study.

Most respondents stated that their expectations from hospitals included accessibility to cancer specialists, quality & expertise of doctors, counseling services, cleanliness & hygiene and all-under-one-roof availability. In the south, especially Chennai, satisfaction level with most parameters while choosing a hospital are higher than other regions. Patient engagement through counseling and timely access to healthcare facilities are clear need gaps to be fulfilled.

Respondents shared that costly treatment options, re-emergence of cancer, lack of counseling to deal with the emotional stress and access to oncologists were the key areas of concern in their personal experience.

Commenting on the report, Dr. Raja Sundaram, Director – Gleneagles Global Institute of Oncology, Gleneagles Global Health City, Chennai, said, “Painful Wait has given us an indication of the ordeal a cancer patient in India has to go through. The report has shed light on many cracks in the system that affects the proper diagnosis and treatment of cancer in our country. While I am glad that our city according to the report ranks higher on satisfaction while choosing a hospital than the other regions, it is still imperative that we listen to the patients and provide better access to oncologists and counselling to help them deal with emotional stress. I sincerely hope that this study creates awareness and helps the eco-system in India understand the gaps to create a better path to recovery for cancer patients.”

Dr. Jagprag Singh Gujral, Group COO of Gleneagles Global Hospitals said, “This national survey is an attempt by us to understand a cancer patients journey from diagnosis to treatment and a commitment to streamline the hospitals clinical and operational interfaces to reduce unwarranted stress for the patient and his care takers. The findings are an eye opener and by all means revolutionary for all stakeholders in the healthcare delivery space. We are confident that this new holistic approach that we are introducing in cancer patient care in India will revolutionize the way healthcare delivery providers look at a patient’s journey from symptomatic diagnosis to treatment. “

Mr. Ramesh Krishnan, CEO – India Operations Division, Parkway Pantai said, “According to the Indian Council of Medical Research (ICMR), the projected figure for new cancer cases in 2016 was 14.5 lakh and by 2020, the number is expected to rise exponentially to 17 lakhs. These numbers are alarming and require collaborative action at both individual and collective levels to make big strides in the fight to cure cancer. We are making a beginning towards serving the unmet needs of patients by creating a pathway, ensuring better patient experience. Through the findings from the research commissioned by us, we will use it to make necessary changes in the way we practice, both clinically and non clinically. Through such initiatives we need to demonstrate control strategies to spread awareness for early detection of cancer and reduce its devastating impact. We also aim to strengthen our resources and provide the best training to meet this increased patient load and deliver quality healthcare”

The study covers 6 major Indian cities including Bangalore, Mumbai, Delhi, Chennai, Kolkata and Hyderabad. A comprehensive sample of 600 cancer patients and survivors were kind enough to be a part of this study. Insights and feedback was collected through in person interactions with cancer survivors between the ages of 20-55 years old.

The IHTC 2017 to take place on the 3rd – 4th March, 2017 in Bengaluru.

IHTC – INTERNATIONAL HEALTHCARE TOURISM CONGRESS is a noted knowledge platform of international standard Healthcare and Tourism in India with an objective to bring together India’s top executives/ decision makers from the health, healthcare and tourism industry, innovative solution providers and stalwarts to discuss on acute technological issues and business challenges currently faced in the Healthcare Sector in the country. It will, therefore, provide maximum inputs of practical knowledge among Medical Tourism Agencies (MTAs), Tourism experts and Medical Marketing heads, addressing sessions on the latest and most recent developments. The IHTC is more than just a Healthcare Tourism conference. It is a dynamic forum packed with Thought Leadership sessions over a period of two days.

By creating a platform and by bringing in all the stakeholders of the Healthcare Tourism Sector under one roof, Ms. Anitha Niranjan, Managing Director – CIMGlobal wants to encourage the strength of the industry just as much. Keynote Address by Prof. Ravi Ramamurti (Distinguished Professor at North-eastern University and The Founding Director of The Center For Emerging Markets, USA). Also, a Parallel session on Outcome based Round table closed door discussion, Emerging Multiple business models and stakeholders in promoting medical tourism

International Healthcare Tourism Congress have successfully acquired attention and support from both State and Central Government as the topics of the congress are well sorted as per the industry needs. Few of the topic for this congress are as follows like Embracing Health Innovation – India’s strength on Health tourism, Telemedicine, Oncology, Organ Transplant, Dentistry, etc.

IHTC 2017 will be successful in planning and designing the congress around the MTA’s and the Industry prerequisites. We are well aware that Healthcare tourism in India is the next crown jewel that could shape the future of India’s economy and hence we are putting effort in gathering the much-required support. The government also estimates that the growth of health-related services will be more than 5 percent for the next 10 years and that should further attract more such visitors.

Major corporations such as Tata, Fortis, Max, Wockhardt, and Apollo Hospitals have made significant investments in setting up modern hospitals and tourism-related services to cater to the new brand of visitors from abroad.

Bengaluru, is a leading player in the Health tourism/healthcare industry. It is increasingly emerging as the destination of choice for a wide range of Health procedures.

• Highest number of JCI hospitals
• The only city in India which has national Institute in Unani medicine
• Good supply source of medical talent. This includes doctors, nurses, pharmacist, lab assistants.
• Cosmopolitan outlook of the city and that is strong on hospitality
• Key source locations are aware of the city and the infrastructure and it can be leveraged. Source location countries for Bengaluru include Middle East and Africa, particularly, Central Africa Kenya, Nigeria, and Ethiopia, but it also gets patients from Oman, Iraq, Bahrain, Sri Lanka, Bangladesh, Maldives, and Myanmar.
• City has well development ecosystem of partners including allied service like language translators
• South India has had a good start in attractive medical tourists and Chennai is leading the visitors in the country.

The event will offer an opportunity to interact with leaders in Health tourism industry, both from local and global partnerships. This will be a platform for Pharma companies, hospitals, Health Tourism Agents, Insurance Companies, Health Technology Manufactures, Wellness and hospitality Industry and healthcare investors to meet & associate.

AHPI and SEMI launched National Cardiac Life Support Programme. Knowledge & Training on Basic and Advanced cardiopulmonary resuscitation (CPR) technique is essential for every health care staff in a hospital including doctors,nurses and paramedical staff. The survival chances in cardiac arrest can be drastically improved with Early identification and immediate resuscitation.

In India, very few healthcare providers are formally trained or certified in such resuscitation techniques which could save thousands of lifes. In view of providing such an essential training to all healthcare providers across our country, at their own work place, The Association of Health Care Providers India (AHPI) have partnered with Society for Emergency Medicine India (SEMI) which is the prime society representing Emergency Medicine in India, for providing a two day cardiac life support program.The program will cover basic and advanced cardiac life support techniques,managing cardiac arrhythmia and providing hands on training in techniques like defibrillation.The training program is also designed to address some of the common problems unique to India including medico legal issues and life support in poisoning, pregnancy, trauma victims & children.

An MOU was signed on 12th January 2017 between AHPI and SEMI in the august presence of presidents and board members of both the associations and the CEO of National Board for Accreditation of Hospitals (NABH).

The Vatika Group, a leading player in the real estate and hospitality business, has decided to exit its healthcare business- Vatika Medicare.

It was only in January 2015 that the group had announced its foray into healthcare. The group began its operations in Delhi-NCR by acquiring two diagnostic labs ‘Health Square’ from Spry Hospitality for Rs 30 crore. Vatika Medicare, which is one of the verticals of Vatika Hotels, had plans of investing Rs 200 crore to open 15 diagnostic centres in tier II cities, beginning with Delhi-NCR. However, the group did not go ahead with rolling out more diagnostic centres.

The group has already exited its diagnostic centre in Gurgaon around 10 months back. The centre was acquired by a group of four doctors. Its second centre, located in Hauz Khas in Delhi, is likely to be acquired by another group of doctors.

Confirming the news, Deepak Uppal, Director, Vatika Medicare, said, “Yes, we are exiting our healthcare vertical by 31st of this month. We have decided to focus on our core business, which is real estate and hotels.”

• The Nuclear Magnetic Resonance (NMR) technology was used to detect the metabolic changes in the surrounding growth medium of the embryos.

• The researchers could detect this change 24 hours before the onset of cell death in the embryos.

Manipal, November 21 : Manipal University research received yet another shot in the arm when a team led by Dr Satish Adiga and Dr. Hanudatta Atreya of Indian Institute of Science (IISc) Bangalore identified a way to predict DNA defects in IVF derived early embryos using a noninvasive technology. Scientific Reports, an esteemed British journal from Nature Group has published this innovative finding today. Last week, the University Researchers had discovered the biomolecules that impede surveillance against infection and promote complications in diabetes.
In this study, the researchers induced DNA lesions experimentally in mouse embryos and observed stark changes in embryo metabolism with high level of DNA damage. The Nuclear Magnetic Resonance (NMR) technology was used to detect the metabolic changes in the surrounding growth medium of the embryos. The researchers could detect this change 24 hours before the onset of cell death in the embryos. This may prove to be extremely advantageous when extrapolated to the clinical IVF set up.

The team included Fiona D’Souza, Shubhashree Uppangala, Guruprasad Kalthur and scientists from IISC and National Centre for Biological Sciences (NCBS), Bangalore.

Vice chancellor, Manipal University, Dr H Vinod Bhat said; “This is a significant step forward by our team towards benefiting infertile couples in improving their IVF success”. Dr Adiga who is also an IVF expert said; “The IVF industry all over the world is striving to increase the success rate by applying invasive tests on the embryos. However, there are ethical and other concerns on using such tests on human embryos. We can now efficiently identify embryos with high amounts of DNA lesions and avoid transferring them to patients as they will eventually fail to implant or result in early pregnancy loss”.

“The study brings out how powerful the small molecule metabolites are when it comes to probing changes happening at a macroscopic or cellular level. This opens up new avenues to probe the response of embryos to various external stimuli” said Dr Atreya who is involved in developing biomarker.

The research work is one of the first reports that document how embryos change their metabolism in response to DNA damage in a controlled set up observed in a mouse model. “Previously in the year 2012, our research team was the first in the country to establish this technology to achieve better implantation rates in infertile patients,” said Dr Poornima Baliga, Dean of Kasturba Medical College, Manipal.
Another renowned IVF specialist Dr Pratap Kumar said that the study gave hope to infertile couples as many of them suffered from failed IVF cycles and many a times the reasons were unknown. Indian Funding agencies such as Department of Science and Technology and Indian Council of Medical Research (ICMR) have supported this work.